Searched for
PFIZER COVID PRODUCTS
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer shares sink after it resets 2024 Covid expectationsRevenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...
- Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlookThese include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...
- Pfizer CEO tests positive for COVID for a second timePfizer Chief Executive Officer Albert Bourla , 60, back in August had contacted COVID and had started a course of the company's oral COVID-...
- China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
- Pfizer's COVID-19 vaccine just received full FDA approval. Here's what it meansIn early August, a Wall Street Journal report stated that India was in talks to buy 50 million doses of Pfizer and German partner BioNTech ...
- Pfizer CEO says India vaccine nod is near, but official hints at indemnity hurdle“I hope very soon we will finalise an agreement with the government,” Bourla said at a virtual event organised by USA-India Chamber of Comm...
- Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine, says PfizerIn a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...
- European Union set to seek clarification from Pfizer over fresh coronavirus vaccine delaysPfizer and the Commission had earlier said that there would be no more slowdowns next week, after supplies were held up this week due to wo...
- Committed to engaging with Indian govt to make vaccine available in country: PfizerThe UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19 with the UK regulator Medicines and He...
- Pfizer-BioNTech's COVID-19 vaccine to prioritise senior citizensEarlier today, the UK became the first country in the world to authorise the use of Pfizer and BioNTech for emergency purposes, thus, pavin...
Load More
